ArticleHuman brain mapping2025
Utility of Harmonisation for Fixel-Based Metrics in Travelling Subjects and Alzheimer's Disease Data.
Article in Human brain mapping, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Utility of Harmonisation for Fixel-Based Metrics in Travelling Subjects and Alzheimer's Disease Data.Human brain mapping · 2025Article
- TRAMFIX: TRavelling Across Melbourne for FIXel-based analysis (a reproducibility and reliability study).Imaging neuroscience (Cambridge, Mass.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Fixel-based analysis (FBA) is an advanced diffusion MRI analysis technique that facilitates the evaluation of white matter microstructure within 'fixels' (specific fibre populations within a voxel). In recent years, FBA has gained prominence for its ability to better characterise fibre tract-specific changes than the more conventional diffusion MRI approaches and has shown promise in elucidating the pathophysiology of psychiatric and neurological diseases. However, FBA has been predominantly limited to single-centre studies, minimising the generalisability of the technique. In this study, the popular ComBat harmonisation technique was adapted for whole-brain FBA of diffusion MRI data. The study evaluates the effectiveness of ComBat in harmonising FBA metrics of fibre density, fibre cross-section and the combined metric of fibre density and cross-section in a large travelling subject dataset (n = 49, scan = 162). Participants were scanned across multiple centres, using different scanner models and imaging protocols, and FBA metrics were compared under these varying conditions before and after harmonisation. In addition, the impact of ComBat harmonisation on disease-related findings was evaluated in an independent multi-centre Alzheimer's disease (AD) dataset, by comparing the same fixel-based measures in patients with AD (n = 27) to those in cognitively normal control participants (n = 29) before and after ComBat harmonisation. We demonstrated that ComBat harmonisation effectively mitigated variability across scanner sites, scanner models, and protocols, in the travelling subject dataset, thus enhancing the comparability of FBA metrics. Notably, ComBat harmonisation improved the detection of AD-related changes in the fornix, a critical white matter tract associated with cognitive function, and strengthened the correlations between FBA metrics and cognitive scores. These results underscore the potential of ComBat harmonisation in enhancing the reliability of multi-centre neuroimaging studies, supporting the use of harmonisation techniques for accurate detection of disease-specific changes in neurodegenerative conditions. The ability to perform ComBat harmonisation within the whole-brain FBA pipeline may help further this fibre-specific technique into large-scale multi-centre studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.